Lessons from the Chinese defective vaccine case

Lancet Infect Dis. 2019 Mar;19(3):245. doi: 10.1016/S1473-3099(19)30062-3.
No abstract available

Publication types

  • Letter

MeSH terms

  • China
  • Counterfeit Drugs*
  • Diphtheria-Tetanus-acellular Pertussis Vaccines / immunology*
  • Drug Approval*
  • Health Policy
  • Humans
  • Rabies Vaccines / immunology*

Substances

  • Counterfeit Drugs
  • Diphtheria-Tetanus-acellular Pertussis Vaccines
  • Rabies Vaccines